{"protocolSection":{"identificationModule":{"nctId":"NCT01227629","orgStudyIdInfo":{"id":"1160.20"},"secondaryIdInfos":[{"id":"PETRO trial","type":"OTHER","domain":"OTHER"}],"organization":{"fullName":"Boehringer Ingelheim","class":"INDUSTRY"},"briefTitle":"PETRO Stroke Prevention in Patients With AF by Treatment With Dabigatran, With and Without Aspirin, Compared to Warfarin","officialTitle":"Dose Exploration in Patients With Atrial Fibrillation"},"statusModule":{"statusVerifiedDate":"2014-04","overallStatus":"COMPLETED","expandedAccessInfo":{"hasExpandedAccess":false},"startDateStruct":{"date":"2003-09"},"primaryCompletionDateStruct":{"date":"2004-11","type":"ACTUAL"},"studyFirstSubmitDate":"2010-10-22","studyFirstSubmitQcDate":"2010-10-22","studyFirstPostDateStruct":{"date":"2010-10-25","type":"ESTIMATED"},"resultsFirstSubmitDate":"2010-11-18","resultsFirstSubmitQcDate":"2011-01-14","resultsFirstPostDateStruct":{"date":"2011-02-10","type":"ESTIMATED"},"lastUpdateSubmitDate":"2014-04-22","lastUpdatePostDateStruct":{"date":"2014-05-05","type":"ESTIMATED"}},"sponsorCollaboratorsModule":{"responsibleParty":{"oldNameTitle":"Boehringer Ingelheim, Study Chair","oldOrganization":"Boehringer Ingelheim"},"leadSponsor":{"name":"Boehringer Ingelheim","class":"INDUSTRY"}},"descriptionModule":{"briefSummary":"The purpose of this trial is to evaluate the safety of different doses of BIBR 1048, alone or in combination with acetylsalicylic acid (ASA), as determined by the rates of bleeding and other adverse events.\n\nA secondary objective of this trial is to evaluate the anticoagulant effect of different doses of BIBR 1048, based on the reduction of plasma concentrations of D-dimer, a laboratory marker for activated coagulation in patients with atrial fibrillation (AF), and to correlate bleeding and other events with pharmacokinetic (PK) and pharmacodynamic (PD) data."},"conditionsModule":{"conditions":["Atrial Fibrillation"]},"designModule":{"studyType":"INTERVENTIONAL","phases":["PHASE2"],"designInfo":{"allocation":"RANDOMIZED","interventionModel":"PARALLEL","primaryPurpose":"PREVENTION"},"enrollmentInfo":{"count":502,"type":"ACTUAL"}},"armsInterventionsModule":{"armGroups":[{"label":"dabigatran 50 mg twice daily (bid)","type":"EXPERIMENTAL","description":"Dabigatran: one capsule in the morning and 1 capsule in the evening. Twice daily (bis in die = bid).","interventionNames":["Drug: dabigatran without ASA"]},{"label":"dabigatran 50 mg bid + 81 mg ASA qd","type":"EXPERIMENTAL","description":"Dabigatran: one capsule in the morning and 1 capsule in the evening. Acetylsalicylic acid (ASA) once daily (quaque dies = qd) in the morning.","interventionNames":["Drug: dabigatran with ASA"]},{"label":"dabigatran 50 mg bid + 325 mg ASA qd","type":"EXPERIMENTAL","description":"Dabigatran: one capsule in the morning and 1 capsule in the evening. ASA in the morning","interventionNames":["Drug: dabigatran with ASA"]},{"label":"dabigatran 150 mg bid","type":"EXPERIMENTAL","description":"Dabigatran: one capsule in the morning and 1 capsule in the evening","interventionNames":["Drug: dabigatran without ASA"]},{"label":"dabigatran 150 mg bid + 81 mg ASA qd","type":"EXPERIMENTAL","description":"Dabigatran: one capsule in the morning and 1 capsule in the evening. ASA in the morning","interventionNames":["Drug: dabigatran with ASA"]},{"label":"dabigatran 150 mg bid + 325 mg ASA qd","type":"EXPERIMENTAL","description":"Dabigatran: one capsule in the morning and 1 capsule in the evening. ASA in the morning","interventionNames":["Drug: dabigatran with ASA"]},{"label":"dabigatran 300 mg bid","type":"EXPERIMENTAL","description":"Dabigatran: one capsule in the morning and 1 capsule in the evening","interventionNames":["Drug: dabigatran without ASA"]},{"label":"dabigatran 300 mg bid + 81 mg ASA qd","type":"EXPERIMENTAL","description":"Dabigatran: one capsule in the morning and 1 capsule in the evening. ASA in the morning","interventionNames":["Drug: dabigatran with ASA"]},{"label":"dabigatran 300 mg bid + 325 mg ASA qd","type":"EXPERIMENTAL","description":"Dabigatran: one capsule in the morning and 1 capsule in the evening. ASA in the morning","interventionNames":["Drug: dabigatran with ASA"]},{"label":"warfarin","type":"ACTIVE_COMPARATOR","description":"once daily, dosed to target International Normalised Ratio (INR) 2.0 to 3.0","interventionNames":["Drug: warfarin"]}],"interventions":[{"type":"DRUG","name":"dabigatran with ASA","description":"dose comparison in combination","armGroupLabels":["dabigatran 50 mg bid + 81 mg ASA qd"]},{"type":"DRUG","name":"dabigatran with ASA","description":"dose comparison in combination","armGroupLabels":["dabigatran 50 mg bid + 325 mg ASA qd"]},{"type":"DRUG","name":"dabigatran with ASA","description":"dose comparison in combination","armGroupLabels":["dabigatran 150 mg bid + 81 mg ASA qd"]},{"type":"DRUG","name":"dabigatran with ASA","description":"dose comparison in combination","armGroupLabels":["dabigatran 150 mg bid + 325 mg ASA qd"]},{"type":"DRUG","name":"dabigatran with ASA","description":"dose comparison in combination","armGroupLabels":["dabigatran 300 mg bid + 81 mg ASA qd"]},{"type":"DRUG","name":"dabigatran with ASA","description":"dose comparison in combination","armGroupLabels":["dabigatran 300 mg bid + 325 mg ASA qd"]},{"type":"DRUG","name":"warfarin","description":"comparator","armGroupLabels":["warfarin"]},{"type":"DRUG","name":"dabigatran without ASA","description":"dose comparison","armGroupLabels":["dabigatran 50 mg twice daily (bid)"]},{"type":"DRUG","name":"dabigatran without ASA","description":"dose comparison","armGroupLabels":["dabigatran 150 mg bid"]},{"type":"DRUG","name":"dabigatran without ASA","description":"dose comparison","armGroupLabels":["dabigatran 300 mg bid"]}]},"outcomesModule":{"primaryOutcomes":[{"measure":"Number of Participants With Fatal or Life-threatening Major Bleeding Events","description":"Retroperitoneal, intracranial, intraocular, or intraspinal bleeding, or requiring surgical treatment, or leading to a transfusion of 2 units or more, or leading to a fall in hemoglobin of 20g/L or more","timeFrame":"12 weeks"},{"measure":"Number of Participants With Minor/Relevant Bleeding Events","description":"Haematuria, rectal bleeding, gingival bleeding, skin hematoma of 25cm\\^2 or more, nose bleed of more than 5 minutes duration, bleeding leading to a hospitalization, leading to a transfusion of less than 2 units or any other clinically relevant bleeding","timeFrame":"12 weeks"},{"measure":"Number of Participants With Minor/Nuisance Bleeding Events","description":"All bleeding events not fulfilling one of the criteria for major bleeding event or minor/relevant bleeding events.","timeFrame":"12 weeks"}],"secondaryOutcomes":[{"measure":"Number of Participants With Thromboembolic Events: Composite Endpoint","description":"Combination of ischemic stroke (fatal or non fatal), transient ischemic attack, systemic thromboembolism, myocardial infarction (fatal or non fatal), other major adverse cardiac event and all cause mortality","timeFrame":"12 weeks"},{"measure":"Number of Participants With Thromboembolic Events: Ischemic Stroke","description":"Occurence of an ischemic stroke (fatal or non-fatal)","timeFrame":"12 weeks"},{"measure":"Thromboembolic Events: Number of Participants With Transient Ischemic Attack","description":"Occurence of a transient ischemic attack","timeFrame":"12 weeks"},{"measure":"Thromboembolic Events: Number of Participants With Systemic Thromboembolism","description":"Occurence of a systemic thromboembolism","timeFrame":"12 weeks"},{"measure":"Thromboembolic Events: Number of Participants With Myocardial Infarction","description":"Occurence of a myocardial infarction","timeFrame":"12 weeks"},{"measure":"Thromboembolic Events: Number of Participants With Other Major Cardiac Events","description":"Occurence of other major adverse cardiac events","timeFrame":"12 weeks"},{"measure":"Thromboembolic Events: Number of Participants Who Died","description":"Occurence of death by all causes","timeFrame":"12 weeks"},{"measure":"D-dimer: Difference From Baseline","description":"Difference in D-dimer from baseline to last available value","timeFrame":"baseline and 12 weeks"},{"measure":"Soluble Fibrin: Difference From Baseline","description":"Difference from baseline to visit 7","timeFrame":"baseline and 12 weeks"},{"measure":"11-dehydrothromboxane B2 (TXB2): Difference From Baseline","description":"Difference from baseline to visit 7","timeFrame":"baseline and 12 weeks"},{"measure":"Ecarin Clotting Time (ECT): Difference From Baseline","timeFrame":"baseline and 12 weeks"},{"measure":"Activated Partial Thromboplastin Time (aPTT): Difference From Baseline","timeFrame":"baseline and 12 weeks"},{"measure":"Trough Plasma Concentration of Dabigatran (BIBR 953)","description":"The values of the trough plasma concentration of dabigatran (BIBR 953) are the by-patient geometric means of week 1, 4 and 12.","timeFrame":"12 weeks"},{"measure":"Number of Participants With Increase of Aspartat-Aminotransferase (AST) to >2*Baseline","description":"Increase of AST to more than two times the baseline value","timeFrame":"12 weeks"},{"measure":"Number of Participants With Increase of Alkaline Phosphatase (AP) to >2*Baseline","description":"Increase of AP to more than two times the baseline value","timeFrame":"12 weeks"},{"measure":"Number of Participants With Increase of Bilirubin to >2*Baseline","description":"Increase of Bilirubin to more than two times the baseline value","timeFrame":"12 weeks"},{"measure":"Number of Participants With Increase of Alanine-Aminotransferase (ALT) to >2*Baseline","description":"Number of Participants with Increase of ALT to more than two times the baseline value","timeFrame":"12 weeks"},{"measure":"Severity of Adverse Events","description":"Total number of patients with any adverse event of worst intensity 'mild', 'moderate' and 'severe'.","timeFrame":"12 weeks"}]},"eligibilityModule":{"eligibilityCriteria":"Inclusion criteria\n\n1. Non-rheumatic atrial fibrillation.\n2. Coronary artery disease (CAD), documented by previous myocard infarction (MI), angina, positive stress test, previous coronary intervention or bypass surgery, or atherosclerotic lesion(s) diagnosed by coronary angiography) is only considered as one of several possible qualifying risk factors. After recruitment of ca. 30%, a protocol amendment 4 was issued so that CAD was only considered as one of several possible qualifying risk factors, 2. see (3 f) below.\n3. An additional risk factor for stroke, i.e. one or more of the following conditions/events:\n\n   1. hypertension (defined as systolic bloodpressure (SBP) \\> 140 mmHg and/or diastolic bloodpressure (DBP) \\> 90 mm Hg) requiring antihypertensive medical treatment.\n   2. diabetes mellitus (type I and II).\n   3. symptomatic heart failure or left ventricular dysfunction (ejection fraction (EF) \\< 40%).\n   4. a previous ischemic stroke or transient ischemic attack.\n   5. age greater than 75 years.\n   6. history of coronary artery disease (by amendment 4)\n4. Treatment with warfarin or other vitamin K dependent anticoagulants for at least 8 weeks prior to inclusion. International normalised ratio (INR) should be within therapeutic range (i.e. INR 2.0 - 3.0) at visit 1 otherwise the visit should be rescheduled.\n5. Age \\> = 18 years at entry.\n6. Written, informed consent.\n\nExclusion criteria\n\n1. Valvular heart disease.\n2. Planned cardioversion.\n3. Recent (=\\< 1 month) myocardial infarction, stroke or transient ischemic attack (TIA), or patients who have received a coronary stent within the last 6 months.\n4. Intolerance or contraindications to acetylsalicylic acid (ASA).\n5. Any contraindication to anticoagulant therapy.\n6. Major bleeding within the last 6 months (other than gastrointestinal (GI) hemorrhage).\n7. Severe renal impairment (estimated glomerular filtration rate (GFR) =\\< 30 mL/min).\n8. Uncontrolled hypertension (SBP \\> 180 mmHg and/or DBP \\> 100 mmHg).\n9. Abnormal liver function as defined by aspartat-aminotransferase (AST), alanin-aminotransferase (ALT), serum bilirubin or alkaline phosphatase (AP) above the reference range, or history of liver disease.\n10. Women who are pregnant or of childbearing potential who refuses to use a medically acceptable form of contraception throughout the study.\n11. Patients who have received an investigational drug within the last 30 days.\n12. Patients scheduled for major surgery or invasive procedures which may cause bleeding, or those who have had major surgery or percutaneous coronary intervention (PCI) within 6 weeks.\n13. Patients considered unreliable by the investigator.\n14. Another indication for anticoagulant treatment.\n15. Patients suffering from anemia.\n16. Patients suffering from thrombocytopenia.\n17. Any other condition which, in the discretion of the investigator, would not allow safe participation in the study.\n18. Concomitant treatment with antiplatelet agents other than ASA.\n19. Recent malignancy or radiation therapy (=\\< 6 month).","healthyVolunteers":false,"sex":"ALL","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"contactsLocationsModule":{"overallOfficials":[{"name":"Boehringer Ingelheim","affiliation":"Boehringer Ingelheim","role":"STUDY_CHAIR"}],"locations":[{"facility":"1160.20.10010","city":"Fayetteville","state":"Arkansas","country":"United States","geoPoint":{"lat":36.06258,"lon":-94.15743}},{"facility":"1160.20.10003 La Mesa Cardiac","city":"La Mesa","state":"California","country":"United States","geoPoint":{"lat":32.76783,"lon":-117.02308}},{"facility":"1160.20.10006 The Ford Research Institute, PA","city":"Pensacola","state":"Florida","country":"United States","geoPoint":{"lat":30.42131,"lon":-87.21691}},{"facility":"1160.20.10004","city":"Port Charlotte","state":"Florida","country":"United States","geoPoint":{"lat":26.97617,"lon":-82.09064}},{"facility":"1160.20.10002","city":"St. Petersburg","state":"Florida","country":"United States","geoPoint":{"lat":27.77086,"lon":-82.67927}},{"facility":"1160.20.10015","city":"Baltimore","state":"Maryland","country":"United States","geoPoint":{"lat":39.29038,"lon":-76.61219}},{"facility":"1160.20.10008","city":"Westminister","state":"Maryland","country":"United States","geoPoint":{"lat":39.64733,"lon":-75.96856}},{"facility":"1160.20.10012","city":"Pittsfield","state":"Massachusetts","country":"United States","geoPoint":{"lat":42.45008,"lon":-73.24538}},{"facility":"1160.20.10007","city":"Troy","state":"Michigan","country":"United States","geoPoint":{"lat":42.60559,"lon":-83.14993}},{"facility":"1160.20.10014","city":"Hawthorne","state":"New York","country":"United States","geoPoint":{"lat":41.10732,"lon":-73.79597}},{"facility":"1160.20.10013","city":"New Hyde Park","state":"New York","country":"United States","geoPoint":{"lat":40.7351,"lon":-73.68791}},{"facility":"1160.20.10009","city":"North Durham","state":"North Carolina","country":"United States","geoPoint":{"lat":35.99403,"lon":-78.89862}},{"facility":"1160.20.10001","city":"Philadelphia","state":"Pennsylvania","country":"United States","geoPoint":{"lat":39.95233,"lon":-75.16379}},{"facility":"1160.20.10005","city":"Germantown","state":"Tennessee","country":"United States","geoPoint":{"lat":35.08676,"lon":-89.81009}},{"facility":"1160.20.45010","city":"Aalborg","country":"Denmark","geoPoint":{"lat":57.048,"lon":9.9187}},{"facility":"1160.20.45005 Aarhus Sygehus","city":"Aarhus C","country":"Denmark","geoPoint":{"lat":56.15674,"lon":10.21076}},{"facility":"1160.20.45007 Medicinsk afdeling","city":"Brædstrup","country":"Denmark","geoPoint":{"lat":55.97153,"lon":9.61129}},{"facility":"1160.20.45011 Medicinsk afd.","city":"Esbjerg","country":"Denmark","geoPoint":{"lat":55.47028,"lon":8.45187}},{"facility":"1160.20.45012 Afdeling B3","city":"Frederikssund","country":"Denmark","geoPoint":{"lat":55.83956,"lon":12.06896}},{"facility":"1160.20.45003 Forskningscentret plan 3","city":"Helsingør","country":"Denmark","geoPoint":{"lat":56.03606,"lon":12.6136}},{"facility":"1160.20.45004 Herlev Hospital","city":"Herlev","country":"Denmark","geoPoint":{"lat":55.72366,"lon":12.43998}},{"facility":"1160.20.45009 Medicinsk amb. B8","city":"Holbæk","country":"Denmark","geoPoint":{"lat":55.71354,"lon":11.7169}},{"facility":"1160.20.45002 Kardiologisk afdeling","city":"Hvidovre","country":"Denmark","geoPoint":{"lat":55.65719,"lon":12.47364}},{"facility":"1160.20.45014 Hjertemedicinsk afd.","city":"Køge","country":"Denmark","geoPoint":{"lat":55.45802,"lon":12.18214}},{"facility":"1160.20.45001 Kardiologisk Laboratorium","city":"Odense","country":"Denmark","geoPoint":{"lat":55.39594,"lon":10.38831}},{"facility":"1160.20.45013 Kardiologisk afd.","city":"Roskilde","country":"Denmark","geoPoint":{"lat":55.64152,"lon":12.08035}},{"facility":"1160.20.45006 Medicinsk afdeling","city":"Svendborg","country":"Denmark","geoPoint":{"lat":55.05982,"lon":10.60677}},{"facility":"1160.20.46013 HIA, Mälarsjukhuset","city":"Eskilstuna","country":"Sweden","geoPoint":{"lat":59.36661,"lon":16.5077}},{"facility":"1160.20.46007 Falu Lasarett","city":"Falun","country":"Sweden","geoPoint":{"lat":60.60357,"lon":15.62597}},{"facility":"1160.20.46005 Ryhovs Länssjukhus","city":"Jönköping","country":"Sweden","geoPoint":{"lat":57.78145,"lon":14.15618}},{"facility":"1160.20.46010 Länssjukhuset Kalmar","city":"Kalmar","country":"Sweden","geoPoint":{"lat":56.66157,"lon":16.36163}},{"facility":"1160.20.46009 Universitetssjukhuset MAS","city":"Malmö","country":"Sweden","geoPoint":{"lat":55.60587,"lon":13.00073}},{"facility":"1160.20.46008 Vrinnevisjukhuset","city":"Norrköping","country":"Sweden","geoPoint":{"lat":58.59419,"lon":16.1826}},{"facility":"1160.20.46002 Södersjukhuset","city":"Stockholm","country":"Sweden","geoPoint":{"lat":59.33258,"lon":18.0649}},{"facility":"1160.20.46011 Arytmienheten, Med klin","city":"Stockholm","country":"Sweden","geoPoint":{"lat":59.33258,"lon":18.0649}},{"facility":"1160.20.46006 Norrlands Universitetssjukhus","city":"Umeå","country":"Sweden","geoPoint":{"lat":63.82842,"lon":20.25972}},{"facility":"1160.20.46003 Centrallasarettet","city":"Västerås","country":"Sweden","geoPoint":{"lat":59.61617,"lon":16.55276}},{"facility":"1160.20.46004 Universitetssjukhuset","city":"Örebro","country":"Sweden","geoPoint":{"lat":59.27412,"lon":15.2066}}]}},"resultsSection":{"participantFlowModule":{"groups":[{"id":"FG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"FG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"FG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"FG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"FG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"FG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"FG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"FG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"FG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"FG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"periods":[{"title":"Overall Study","milestones":[{"type":"STARTED","achievements":[{"groupId":"FG000","comment":"Started: Participant was randomised and took at least one dose of randomised study medication","numSubjects":"58"},{"groupId":"FG001","numSubjects":"20"},{"groupId":"FG002","numSubjects":"27"},{"groupId":"FG003","numSubjects":"99"},{"groupId":"FG004","numSubjects":"34"},{"groupId":"FG005","numSubjects":"33"},{"groupId":"FG006","numSubjects":"98"},{"groupId":"FG007","numSubjects":"33"},{"groupId":"FG008","numSubjects":"30"},{"groupId":"FG009","numSubjects":"70"}]},{"type":"COMPLETED","achievements":[{"groupId":"FG000","comment":"Completed: Participant without premature discontinuation in the randomised treatment period","numSubjects":"56"},{"groupId":"FG001","numSubjects":"18"},{"groupId":"FG002","numSubjects":"26"},{"groupId":"FG003","numSubjects":"91"},{"groupId":"FG004","numSubjects":"32"},{"groupId":"FG005","numSubjects":"32"},{"groupId":"FG006","numSubjects":"90"},{"groupId":"FG007","numSubjects":"27"},{"groupId":"FG008","numSubjects":"24"},{"groupId":"FG009","numSubjects":"68"}]},{"type":"NOT COMPLETED","achievements":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"8"},{"groupId":"FG004","numSubjects":"2"},{"groupId":"FG005","numSubjects":"1"},{"groupId":"FG006","numSubjects":"8"},{"groupId":"FG007","numSubjects":"6"},{"groupId":"FG008","numSubjects":"6"},{"groupId":"FG009","numSubjects":"2"}]}],"dropWithdraws":[{"type":"Adverse Event","reasons":[{"groupId":"FG000","numSubjects":"2"},{"groupId":"FG001","numSubjects":"2"},{"groupId":"FG002","numSubjects":"1"},{"groupId":"FG003","numSubjects":"6"},{"groupId":"FG004","numSubjects":"1"},{"groupId":"FG005","numSubjects":"1"},{"groupId":"FG006","numSubjects":"6"},{"groupId":"FG007","numSubjects":"6"},{"groupId":"FG008","numSubjects":"4"},{"groupId":"FG009","numSubjects":"0"}]},{"type":"Protocol Violation","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"}]},{"type":"Lost to Follow-up","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"1"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"0"}]},{"type":"Withdrawal by Subject","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"0"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"2"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"0"},{"groupId":"FG009","numSubjects":"1"}]},{"type":"Other","reasons":[{"groupId":"FG000","numSubjects":"0"},{"groupId":"FG001","numSubjects":"0"},{"groupId":"FG002","numSubjects":"0"},{"groupId":"FG003","numSubjects":"1"},{"groupId":"FG004","numSubjects":"0"},{"groupId":"FG005","numSubjects":"0"},{"groupId":"FG006","numSubjects":"0"},{"groupId":"FG007","numSubjects":"0"},{"groupId":"FG008","numSubjects":"2"},{"groupId":"FG009","numSubjects":"1"}]}]}]},"baselineCharacteristicsModule":{"groups":[{"id":"BG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"BG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"BG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"BG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"BG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"BG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"BG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"BG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"BG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"BG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"},{"id":"BG010","title":"Total","description":"Total of all reporting groups"}],"denoms":[{"units":"Participants","counts":[{"groupId":"BG000","value":"58"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"27"},{"groupId":"BG003","value":"99"},{"groupId":"BG004","value":"34"},{"groupId":"BG005","value":"33"},{"groupId":"BG006","value":"98"},{"groupId":"BG007","value":"33"},{"groupId":"BG008","value":"30"},{"groupId":"BG009","value":"70"},{"groupId":"BG010","value":"502"}]}],"measures":[{"title":"Age, Continuous","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"Years","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"69.0","spread":"8.8"},{"groupId":"BG001","value":"70.1","spread":"9.4"},{"groupId":"BG002","value":"71.6","spread":"8.1"},{"groupId":"BG003","value":"69.7","spread":"7.7"},{"groupId":"BG004","value":"72.1","spread":"9.0"},{"groupId":"BG005","value":"69.7","spread":"8.0"},{"groupId":"BG006","value":"69.0","spread":"9.1"},{"groupId":"BG007","value":"71.8","spread":"7.2"},{"groupId":"BG008","value":"68.6","spread":"7.1"},{"groupId":"BG009","value":"69.0","spread":"8.3"},{"groupId":"BG010","value":"69.7","spread":"8.3"}]}]}]},{"title":"Sex: Female, Male","paramType":"COUNT_OF_PARTICIPANTS","unitOfMeasure":"Participants","classes":[{"categories":[{"title":"Female","measurements":[{"groupId":"BG000","value":"12"},{"groupId":"BG001","value":"4"},{"groupId":"BG002","value":"5"},{"groupId":"BG003","value":"15"},{"groupId":"BG004","value":"8"},{"groupId":"BG005","value":"8"},{"groupId":"BG006","value":"19"},{"groupId":"BG007","value":"7"},{"groupId":"BG008","value":"2"},{"groupId":"BG009","value":"11"},{"groupId":"BG010","value":"91"}]},{"title":"Male","measurements":[{"groupId":"BG000","value":"46"},{"groupId":"BG001","value":"16"},{"groupId":"BG002","value":"22"},{"groupId":"BG003","value":"84"},{"groupId":"BG004","value":"26"},{"groupId":"BG005","value":"25"},{"groupId":"BG006","value":"79"},{"groupId":"BG007","value":"26"},{"groupId":"BG008","value":"28"},{"groupId":"BG009","value":"59"},{"groupId":"BG010","value":"411"}]}]}]},{"title":"Baseline documentation regarding the atrial fibrillation","paramType":"NUMBER","unitOfMeasure":"Participants","classes":[{"title":"Persistent","categories":[{"measurements":[{"groupId":"BG000","value":"20"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"10"},{"groupId":"BG003","value":"43"},{"groupId":"BG004","value":"13"},{"groupId":"BG005","value":"10"},{"groupId":"BG006","value":"37"},{"groupId":"BG007","value":"14"},{"groupId":"BG008","value":"12"},{"groupId":"BG009","value":"27"},{"groupId":"BG010","value":"195"}]}]},{"title":"Permanent","categories":[{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"9"},{"groupId":"BG002","value":"11"},{"groupId":"BG003","value":"35"},{"groupId":"BG004","value":"11"},{"groupId":"BG005","value":"16"},{"groupId":"BG006","value":"37"},{"groupId":"BG007","value":"10"},{"groupId":"BG008","value":"14"},{"groupId":"BG009","value":"26"},{"groupId":"BG010","value":"192"}]}]},{"title":"Paroxysmal","categories":[{"measurements":[{"groupId":"BG000","value":"15"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"6"},{"groupId":"BG003","value":"21"},{"groupId":"BG004","value":"10"},{"groupId":"BG005","value":"7"},{"groupId":"BG006","value":"24"},{"groupId":"BG007","value":"9"},{"groupId":"BG008","value":"4"},{"groupId":"BG009","value":"17"},{"groupId":"BG010","value":"115"}]}]}]},{"title":"Baseline documentation regarding stroke","description":"Documentation of stroke as specific risk factor","paramType":"NUMBER","unitOfMeasure":"Participants","classes":[{"title":"No","categories":[{"measurements":[{"groupId":"BG000","value":"54"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"24"},{"groupId":"BG003","value":"93"},{"groupId":"BG004","value":"30"},{"groupId":"BG005","value":"30"},{"groupId":"BG006","value":"91"},{"groupId":"BG007","value":"31"},{"groupId":"BG008","value":"26"},{"groupId":"BG009","value":"62"},{"groupId":"BG010","value":"459"}]}]},{"title":"Yes","categories":[{"measurements":[{"groupId":"BG000","value":"4"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"3"},{"groupId":"BG003","value":"6"},{"groupId":"BG004","value":"4"},{"groupId":"BG005","value":"3"},{"groupId":"BG006","value":"7"},{"groupId":"BG007","value":"2"},{"groupId":"BG008","value":"4"},{"groupId":"BG009","value":"8"},{"groupId":"BG010","value":"43"}]}]}]},{"title":"Baseline documentation regarding transient ischemic attack","description":"Documentation of transient ischemic attack as specific risk factor","paramType":"NUMBER","unitOfMeasure":"Participants","classes":[{"title":"No","categories":[{"measurements":[{"groupId":"BG000","value":"49"},{"groupId":"BG001","value":"20"},{"groupId":"BG002","value":"25"},{"groupId":"BG003","value":"88"},{"groupId":"BG004","value":"31"},{"groupId":"BG005","value":"31"},{"groupId":"BG006","value":"90"},{"groupId":"BG007","value":"30"},{"groupId":"BG008","value":"26"},{"groupId":"BG009","value":"63"},{"groupId":"BG010","value":"453"}]}]},{"title":"Yes","categories":[{"measurements":[{"groupId":"BG000","value":"9"},{"groupId":"BG001","value":"0"},{"groupId":"BG002","value":"2"},{"groupId":"BG003","value":"11"},{"groupId":"BG004","value":"3"},{"groupId":"BG005","value":"2"},{"groupId":"BG006","value":"8"},{"groupId":"BG007","value":"3"},{"groupId":"BG008","value":"4"},{"groupId":"BG009","value":"7"},{"groupId":"BG010","value":"49"}]}]}]},{"title":"Baseline documentation regarding transient ischemic attack or stroke","description":"Documentation of transient ischemic attack or stroke as specific risk factor","paramType":"NUMBER","unitOfMeasure":"Participants","classes":[{"title":"No","categories":[{"measurements":[{"groupId":"BG000","value":"45"},{"groupId":"BG001","value":"18"},{"groupId":"BG002","value":"23"},{"groupId":"BG003","value":"82"},{"groupId":"BG004","value":"27"},{"groupId":"BG005","value":"28"},{"groupId":"BG006","value":"85"},{"groupId":"BG007","value":"28"},{"groupId":"BG008","value":"22"},{"groupId":"BG009","value":"57"},{"groupId":"BG010","value":"415"}]}]},{"title":"Yes","categories":[{"measurements":[{"groupId":"BG000","value":"13"},{"groupId":"BG001","value":"2"},{"groupId":"BG002","value":"4"},{"groupId":"BG003","value":"17"},{"groupId":"BG004","value":"7"},{"groupId":"BG005","value":"5"},{"groupId":"BG006","value":"13"},{"groupId":"BG007","value":"5"},{"groupId":"BG008","value":"8"},{"groupId":"BG009","value":"13"},{"groupId":"BG010","value":"87"}]}]}]},{"title":"Baseline documentation regarding hypertension","description":"Documentation of hypertension as specific risk factor","paramType":"NUMBER","unitOfMeasure":"Participants","classes":[{"title":"No","categories":[{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"8"},{"groupId":"BG003","value":"21"},{"groupId":"BG004","value":"13"},{"groupId":"BG005","value":"14"},{"groupId":"BG006","value":"24"},{"groupId":"BG007","value":"8"},{"groupId":"BG008","value":"10"},{"groupId":"BG009","value":"21"},{"groupId":"BG010","value":"146"}]}]},{"title":"Yes","categories":[{"measurements":[{"groupId":"BG000","value":"41"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"19"},{"groupId":"BG003","value":"78"},{"groupId":"BG004","value":"21"},{"groupId":"BG005","value":"19"},{"groupId":"BG006","value":"74"},{"groupId":"BG007","value":"25"},{"groupId":"BG008","value":"20"},{"groupId":"BG009","value":"49"},{"groupId":"BG010","value":"356"}]}]}]},{"title":"Baseline documentation regarding symptomatic heart failure","description":"Documentation of symptomatic heart failure as specific risk factor","paramType":"NUMBER","unitOfMeasure":"Participants","classes":[{"title":"No","categories":[{"measurements":[{"groupId":"BG000","value":"41"},{"groupId":"BG001","value":"12"},{"groupId":"BG002","value":"17"},{"groupId":"BG003","value":"73"},{"groupId":"BG004","value":"20"},{"groupId":"BG005","value":"21"},{"groupId":"BG006","value":"85"},{"groupId":"BG007","value":"20"},{"groupId":"BG008","value":"20"},{"groupId":"BG009","value":"46"},{"groupId":"BG010","value":"355"}]}]},{"title":"Yes","categories":[{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"8"},{"groupId":"BG002","value":"10"},{"groupId":"BG003","value":"26"},{"groupId":"BG004","value":"14"},{"groupId":"BG005","value":"12"},{"groupId":"BG006","value":"13"},{"groupId":"BG007","value":"13"},{"groupId":"BG008","value":"10"},{"groupId":"BG009","value":"24"},{"groupId":"BG010","value":"147"}]}]}]},{"title":"Baseline documentation regarding left ventricular dysfunction","description":"Documentation of left ventricular dysfunction as specific risk factor","paramType":"NUMBER","unitOfMeasure":"Participants","classes":[{"title":"No","categories":[{"measurements":[{"groupId":"BG000","value":"41"},{"groupId":"BG001","value":"14"},{"groupId":"BG002","value":"17"},{"groupId":"BG003","value":"68"},{"groupId":"BG004","value":"22"},{"groupId":"BG005","value":"19"},{"groupId":"BG006","value":"78"},{"groupId":"BG007","value":"20"},{"groupId":"BG008","value":"14"},{"groupId":"BG009","value":"44"},{"groupId":"BG010","value":"337"}]}]},{"title":"Yes","categories":[{"measurements":[{"groupId":"BG000","value":"17"},{"groupId":"BG001","value":"6"},{"groupId":"BG002","value":"10"},{"groupId":"BG003","value":"31"},{"groupId":"BG004","value":"12"},{"groupId":"BG005","value":"14"},{"groupId":"BG006","value":"20"},{"groupId":"BG007","value":"13"},{"groupId":"BG008","value":"16"},{"groupId":"BG009","value":"26"},{"groupId":"BG010","value":"165"}]}]}]},{"title":"Baseline documentation regarding symptomatic heart failure or left ventricular dysfunction","description":"Documentation of symptomatic heart failure or left ventricular dysfunction as specific risk factor","paramType":"NUMBER","unitOfMeasure":"Participants","classes":[{"title":"No","categories":[{"measurements":[{"groupId":"BG000","value":"35"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"14"},{"groupId":"BG003","value":"55"},{"groupId":"BG004","value":"15"},{"groupId":"BG005","value":"17"},{"groupId":"BG006","value":"71"},{"groupId":"BG007","value":"14"},{"groupId":"BG008","value":"12"},{"groupId":"BG009","value":"34"},{"groupId":"BG010","value":"277"}]}]},{"title":"Yes","categories":[{"measurements":[{"groupId":"BG000","value":"23"},{"groupId":"BG001","value":"10"},{"groupId":"BG002","value":"13"},{"groupId":"BG003","value":"44"},{"groupId":"BG004","value":"19"},{"groupId":"BG005","value":"16"},{"groupId":"BG006","value":"27"},{"groupId":"BG007","value":"19"},{"groupId":"BG008","value":"18"},{"groupId":"BG009","value":"36"},{"groupId":"BG010","value":"225"}]}]}]},{"title":"Coronary Artery Disease","description":"Documentation of Coronary Artery Disease as inclusion criterion or specific risk factor","paramType":"NUMBER","unitOfMeasure":"participants","classes":[{"title":"no","categories":[{"measurements":[{"groupId":"BG000","value":"39"},{"groupId":"BG001","value":"1"},{"groupId":"BG002","value":"1"},{"groupId":"BG003","value":"55"},{"groupId":"BG004","value":"3"},{"groupId":"BG005","value":"4"},{"groupId":"BG006","value":"62"},{"groupId":"BG007","value":"2"},{"groupId":"BG008","value":"1"},{"groupId":"BG009","value":"28"},{"groupId":"BG010","value":"196"}]}]},{"title":"yes","categories":[{"measurements":[{"groupId":"BG000","value":"19"},{"groupId":"BG001","value":"19"},{"groupId":"BG002","value":"26"},{"groupId":"BG003","value":"44"},{"groupId":"BG004","value":"31"},{"groupId":"BG005","value":"29"},{"groupId":"BG006","value":"36"},{"groupId":"BG007","value":"31"},{"groupId":"BG008","value":"29"},{"groupId":"BG009","value":"42"},{"groupId":"BG010","value":"306"}]}]}]},{"title":"D-dimer at baseline N=(56;19;25;88;29;32;85;31;29;63;457)","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"ng/ml","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"106.8","spread":"104.1"},{"groupId":"BG001","value":"104.5","spread":"62.9"},{"groupId":"BG002","value":"176.9","spread":"389.9"},{"groupId":"BG003","value":"100.8","spread":"94.5"},{"groupId":"BG004","value":"120.3","spread":"95.4"},{"groupId":"BG005","value":"96.3","spread":"64.3"},{"groupId":"BG006","value":"146.8","spread":"210.9"},{"groupId":"BG007","value":"119.4","spread":"95.5"},{"groupId":"BG008","value":"83.8","spread":"48.8"},{"groupId":"BG009","value":"139.9","spread":"251.9"},{"groupId":"BG010","value":"120.9","spread":"173.7"}]}]}]},{"title":"Soluble fibrin at baseline N=(53;16;23;88;27;29;92;30;25;65;448)","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"µg/ml","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"4.9","spread":"4.4"},{"groupId":"BG001","value":"5.3","spread":"7.9"},{"groupId":"BG002","value":"5.4","spread":"5.9"},{"groupId":"BG003","value":"5.8","spread":"8.8"},{"groupId":"BG004","value":"9.1","spread":"15.5"},{"groupId":"BG005","value":"7.6","spread":"14.8"},{"groupId":"BG006","value":"7.4","spread":"11.5"},{"groupId":"BG007","value":"9.2","spread":"26.0"},{"groupId":"BG008","value":"6.5","spread":"9.2"},{"groupId":"BG009","value":"7.2","spread":"10.4"},{"groupId":"BG010","value":"6.8","spread":"11.9"}]}]}]},{"title":"Thromboxane B2 (TXB2) measured at baseline N=(53;20;23;93;30;30;90;31;30;67;467)","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"pg/mg Creatinine","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"3968.5","spread":"2530.4"},{"groupId":"BG001","value":"3795.9","spread":"2252.9"},{"groupId":"BG002","value":"4705.6","spread":"3047.5"},{"groupId":"BG003","value":"4138.1","spread":"2184.6"},{"groupId":"BG004","value":"4485.7","spread":"2147.8"},{"groupId":"BG005","value":"4084.9","spread":"2253.5"},{"groupId":"BG006","value":"3619.0","spread":"2020.6"},{"groupId":"BG007","value":"4450.8","spread":"2653.7"},{"groupId":"BG008","value":"3735.6","spread":"2440.6"},{"groupId":"BG009","value":"4177.9","spread":"2661.2"},{"groupId":"BG010","value":"4051.6","spread":"2367.7"}]}]}]},{"title":"ECT at baseline N=(57;20;27;98;34;33;95;33;29;56;482)","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"seconds","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"32.3","spread":"2.0"},{"groupId":"BG001","value":"31.8","spread":"1.9"},{"groupId":"BG002","value":"31.9","spread":"2.2"},{"groupId":"BG003","value":"31.9","spread":"2.2"},{"groupId":"BG004","value":"32.0","spread":"1.9"},{"groupId":"BG005","value":"32.6","spread":"2.4"},{"groupId":"BG006","value":"33.6","spread":"13.3"},{"groupId":"BG007","value":"31.9","spread":"1.8"},{"groupId":"BG008","value":"32.2","spread":"2.6"},{"groupId":"BG009","value":"32.0","spread":"2.4"},{"groupId":"BG010","value":"32.4","spread":"6.2"}]}]}]},{"title":"aPTT at baseline N=(57;20;27;98;34;33;96;33;29;57;484)","paramType":"MEAN","dispersionType":"STANDARD_DEVIATION","unitOfMeasure":"seconds","classes":[{"categories":[{"measurements":[{"groupId":"BG000","value":"32.5","spread":"3.0"},{"groupId":"BG001","value":"31.2","spread":"3.5"},{"groupId":"BG002","value":"32.4","spread":"3.6"},{"groupId":"BG003","value":"34.2","spread":"15.2"},{"groupId":"BG004","value":"33.5","spread":"7.6"},{"groupId":"BG005","value":"34.2","spread":"6.7"},{"groupId":"BG006","value":"32.8","spread":"5.7"},{"groupId":"BG007","value":"32.6","spread":"3.4"},{"groupId":"BG008","value":"32.9","spread":"6.7"},{"groupId":"BG009","value":"33.2","spread":"3.7"},{"groupId":"BG010","value":"33.1","spread":"8.2"}]}]}]}]},"outcomeMeasuresModule":{"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Fatal or Life-threatening Major Bleeding Events","description":"Retroperitoneal, intracranial, intraocular, or intraspinal bleeding, or requiring surgical treatment, or leading to a transfusion of 2 units or more, or leading to a fall in hemoglobin of 20g/L or more","populationDescription":"All treated patients. No statistical comparisons were performed, due to the extremely small number of events.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"100"},{"groupId":"OG004","value":"36"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"105"},{"groupId":"OG007","value":"34"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"1"},{"groupId":"OG008","value":"3"},{"groupId":"OG009","value":"0"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Minor/Relevant Bleeding Events","description":"Haematuria, rectal bleeding, gingival bleeding, skin hematoma of 25cm\\^2 or more, nose bleed of more than 5 minutes duration, bleeding leading to a hospitalization, leading to a transfusion of less than 2 units or any other clinically relevant bleeding","populationDescription":"All treated patients. No statistical comparisons were performed, due to the small number of events per group","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"100"},{"groupId":"OG004","value":"36"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"105"},{"groupId":"OG007","value":"34"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"9"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"2"},{"groupId":"OG006","value":"6"},{"groupId":"OG007","value":"4"},{"groupId":"OG008","value":"3"},{"groupId":"OG009","value":"4"}]}]}]},{"type":"PRIMARY","title":"Number of Participants With Minor/Nuisance Bleeding Events","description":"All bleeding events not fulfilling one of the criteria for major bleeding event or minor/relevant bleeding events.","populationDescription":"All treated patients. No statistical comparisons were performed, due to the small number of events per group","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"21"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"100"},{"groupId":"OG004","value":"36"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"105"},{"groupId":"OG007","value":"34"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"2"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"6"},{"groupId":"OG005","value":"5"},{"groupId":"OG006","value":"9"},{"groupId":"OG007","value":"7"},{"groupId":"OG008","value":"9"},{"groupId":"OG009","value":"9"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Thromboembolic Events: Composite Endpoint","description":"Combination of ischemic stroke (fatal or non fatal), transient ischemic attack, systemic thromboembolism, myocardial infarction (fatal or non fatal), other major adverse cardiac event and all cause mortality","populationDescription":"All randomized patients. No statistical comparisons were performed, due to the extremely small number of events.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"99"},{"groupId":"OG004","value":"34"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"98"},{"groupId":"OG007","value":"33"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Thromboembolic Events: Ischemic Stroke","description":"Occurence of an ischemic stroke (fatal or non-fatal)","populationDescription":"All randomized patients. No statistical comparisons were performed, due to the extremely small number of events.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"99"},{"groupId":"OG004","value":"34"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"98"},{"groupId":"OG007","value":"33"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}],"classes":[{"title":"None","categories":[{"measurements":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"19"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"99"},{"groupId":"OG004","value":"34"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"98"},{"groupId":"OG007","value":"33"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}]},{"title":"Fatal","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"0"}]}]},{"title":"Non-Fatal","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"0"}]}]},{"title":"Both","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"0"}]}]}]},{"type":"SECONDARY","title":"Thromboembolic Events: Number of Participants With Transient Ischemic Attack","description":"Occurence of a transient ischemic attack","populationDescription":"All randomized patients. No statistical comparisons were performed, due to the extremely small number of events.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"99"},{"groupId":"OG004","value":"34"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"98"},{"groupId":"OG007","value":"33"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"0"}]}]}]},{"type":"SECONDARY","title":"Thromboembolic Events: Number of Participants With Systemic Thromboembolism","description":"Occurence of a systemic thromboembolism","populationDescription":"All randomized patients. No statistical comparisons were performed, due to the extremely small number of events.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"99"},{"groupId":"OG004","value":"34"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"98"},{"groupId":"OG007","value":"33"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"0"}]}]}]},{"type":"SECONDARY","title":"Thromboembolic Events: Number of Participants With Myocardial Infarction","description":"Occurence of a myocardial infarction","populationDescription":"All randomized patients. No statistical comparisons were performed, due to the extremely small number of events.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"99"},{"groupId":"OG004","value":"34"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"98"},{"groupId":"OG007","value":"33"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}],"classes":[{"title":"None","categories":[{"measurements":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"99"},{"groupId":"OG004","value":"34"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"98"},{"groupId":"OG007","value":"33"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}]},{"title":"Fatal","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"0"}]}]},{"title":"Non-Fatal","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"0"}]}]},{"title":"Both","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"0"}]}]}]},{"type":"SECONDARY","title":"Thromboembolic Events: Number of Participants With Other Major Cardiac Events","description":"Occurence of other major adverse cardiac events","populationDescription":"All randomized patients. No statistical comparisons were performed, due to the extremely small number of events.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"99"},{"groupId":"OG004","value":"34"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"98"},{"groupId":"OG007","value":"33"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"0"}]}]}]},{"type":"SECONDARY","title":"Thromboembolic Events: Number of Participants Who Died","description":"Occurence of death by all causes","populationDescription":"All randomized patients. No statistical comparisons were performed, due to the extremely small number of events.","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"99"},{"groupId":"OG004","value":"34"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"98"},{"groupId":"OG007","value":"33"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"0"}]}]}]},{"type":"SECONDARY","title":"D-dimer: Difference From Baseline","description":"Difference in D-dimer from baseline to last available value","populationDescription":"All randomised patients, only per-protocol data included.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"ng/ml","timeFrame":"baseline and 12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"55"},{"groupId":"OG001","value":"19"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"87"},{"groupId":"OG004","value":"29"},{"groupId":"OG005","value":"32"},{"groupId":"OG006","value":"88"},{"groupId":"OG007","value":"29"},{"groupId":"OG008","value":"29"},{"groupId":"OG009","value":"63"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"22.3","spread":"65.4"},{"groupId":"OG001","value":"12.3","spread":"25.3"},{"groupId":"OG002","value":"50.2","spread":"182.8"},{"groupId":"OG003","value":"8.1","spread":"41.6"},{"groupId":"OG004","value":"29.1","spread":"90.4"},{"groupId":"OG005","value":"8.6","spread":"49.2"},{"groupId":"OG006","value":"4.2","spread":"95.8"},{"groupId":"OG007","value":"11.3","spread":"82.2"},{"groupId":"OG008","value":"-7.9","spread":"40.9"},{"groupId":"OG009","value":"-5.8","spread":"50.6"}]}]}],"analyses":[{"groupIds":["OG000","OG001","OG002","OG003","OG004","OG005","OG006","OG007","OG008","OG009"],"groupDescription":"Group comparison of differences from baseline to last available value","testedNonInferiority":false,"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.0357","statisticalMethod":"Kruskal-Wallis","ciPctValue":"95"}]},{"type":"SECONDARY","title":"Soluble Fibrin: Difference From Baseline","description":"Difference from baseline to visit 7","populationDescription":"All randomised patients, only per-protocol data included.","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"µg/ml","timeFrame":"baseline and 12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"52"},{"groupId":"OG001","value":"15"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"88"},{"groupId":"OG004","value":"25"},{"groupId":"OG005","value":"24"},{"groupId":"OG006","value":"83"},{"groupId":"OG007","value":"27"},{"groupId":"OG008","value":"20"},{"groupId":"OG009","value":"54"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"3.2","spread":"22.0"},{"groupId":"OG001","value":"0.9","spread":"2.3"},{"groupId":"OG002","value":"1.2","spread":"8.4"},{"groupId":"OG003","value":"0.3","spread":"5.1"},{"groupId":"OG004","value":"-2.0","spread":"9.9"},{"groupId":"OG005","value":"-1.3","spread":"8.8"},{"groupId":"OG006","value":"2.3","spread":"26.8"},{"groupId":"OG007","value":"-0.7","spread":"4.6"},{"groupId":"OG008","value":"-1.9","spread":"12.0"},{"groupId":"OG009","value":"0.1","spread":"4.0"}]}]}],"analyses":[{"groupIds":["OG000","OG001","OG002","OG003","OG004","OG005","OG006","OG007","OG008","OG009"],"groupDescription":"Group comparison of differences from baseline to week 12","testedNonInferiority":false,"nonInferiorityType":"SUPERIORITY_OR_OTHER","pValue":"0.26711","statisticalMethod":"Kruskal-Wallis","ciPctValue":"95"}]},{"type":"SECONDARY","title":"11-dehydrothromboxane B2 (TXB2): Difference From Baseline","description":"Difference from baseline to visit 7","populationDescription":"All treated patients. No statistical comparisons due to high variability","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"pg/mg Creatinine","timeFrame":"baseline and 12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"44"},{"groupId":"OG001","value":"17"},{"groupId":"OG002","value":"19"},{"groupId":"OG003","value":"73"},{"groupId":"OG004","value":"25"},{"groupId":"OG005","value":"27"},{"groupId":"OG006","value":"73"},{"groupId":"OG007","value":"25"},{"groupId":"OG008","value":"25"},{"groupId":"OG009","value":"51"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"596.5","spread":"2896.3"},{"groupId":"OG001","value":"-1816.8","spread":"2186.1"},{"groupId":"OG002","value":"-2779.8","spread":"2953.3"},{"groupId":"OG003","value":"922.0","spread":"3874.0"},{"groupId":"OG004","value":"-1988.6","spread":"2187.5"},{"groupId":"OG005","value":"-1125.9","spread":"3566.6"},{"groupId":"OG006","value":"1059.7","spread":"2216.8"},{"groupId":"OG007","value":"-1822.6","spread":"2381.7"},{"groupId":"OG008","value":"-1337.8","spread":"2279.2"},{"groupId":"OG009","value":"203.5","spread":"2109.0"}]}]}]},{"type":"SECONDARY","title":"Ecarin Clotting Time (ECT): Difference From Baseline","populationDescription":"All treated patients. No statistical comparisons due to high variability","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"seconds","timeFrame":"baseline and 12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"56"},{"groupId":"OG001","value":"19"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"94"},{"groupId":"OG004","value":"34"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"86"},{"groupId":"OG007","value":"29"},{"groupId":"OG008","value":"27"},{"groupId":"OG009","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"9.7","spread":"8.2"},{"groupId":"OG001","value":"12.0","spread":"10.7"},{"groupId":"OG002","value":"12.0","spread":"9.6"},{"groupId":"OG003","value":"31.9","spread":"26.2"},{"groupId":"OG004","value":"42.5","spread":"29.2"},{"groupId":"OG005","value":"32.7","spread":"23.1"},{"groupId":"OG006","value":"63.6","spread":"44.8"},{"groupId":"OG007","value":"70.8","spread":"60.3"},{"groupId":"OG008","value":"74.0","spread":"70.5"},{"groupId":"OG009","value":"3.1","spread":"2.5"}]}]}]},{"type":"SECONDARY","title":"Activated Partial Thromboplastin Time (aPTT): Difference From Baseline","populationDescription":"All treated patients. No statistical comparisons due to high variability","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"seconds","timeFrame":"baseline and 12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"56"},{"groupId":"OG001","value":"19"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"92"},{"groupId":"OG004","value":"33"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"87"},{"groupId":"OG007","value":"29"},{"groupId":"OG008","value":"27"},{"groupId":"OG009","value":"27"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"6.4","spread":"5.6"},{"groupId":"OG001","value":"8.3","spread":"6.1"},{"groupId":"OG002","value":"8.8","spread":"9.4"},{"groupId":"OG003","value":"13.5","spread":"18.3"},{"groupId":"OG004","value":"24.9","spread":"26.1"},{"groupId":"OG005","value":"14.5","spread":"11.5"},{"groupId":"OG006","value":"25.0","spread":"12.4"},{"groupId":"OG007","value":"23.4","spread":"12.7"},{"groupId":"OG008","value":"27.2","spread":"24.2"},{"groupId":"OG009","value":"8.8","spread":"6.7"}]}]}]},{"type":"SECONDARY","title":"Trough Plasma Concentration of Dabigatran (BIBR 953)","description":"The values of the trough plasma concentration of dabigatran (BIBR 953) are the by-patient geometric means of week 1, 4 and 12.","populationDescription":"All treated patients","reportingStatus":"POSTED","paramType":"MEAN","dispersionType":"Standard Deviation","unitOfMeasure":"ng/ml","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"99"},{"groupId":"OG004","value":"34"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"97"},{"groupId":"OG007","value":"33"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}],"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"29.1","spread":"16.6"},{"groupId":"OG001","value":"30.4","spread":"16.6"},{"groupId":"OG002","value":"31.8","spread":"20.0"},{"groupId":"OG003","value":"82.8","spread":"54.3"},{"groupId":"OG004","value":"103.2","spread":"69.0"},{"groupId":"OG005","value":"90.1","spread":"52.5"},{"groupId":"OG006","value":"188.0","spread":"117.3"},{"groupId":"OG007","value":"203.7","spread":"123.9"},{"groupId":"OG008","value":"207.6","spread":"108.7"},{"groupId":"OG009","value":"NA","spread":"NA"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Increase of Aspartat-Aminotransferase (AST) to >2*Baseline","description":"Increase of AST to more than two times the baseline value","populationDescription":"All treated patients. No statistical comparisons due to extremely small number of cases","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"99"},{"groupId":"OG004","value":"34"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"98"},{"groupId":"OG007","value":"33"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}],"classes":[{"title":"Missing","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"1"},{"groupId":"OG007","value":"1"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"1"}]}]},{"title":"No","categories":[{"measurements":[{"groupId":"OG000","value":"57"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"24"},{"groupId":"OG003","value":"93"},{"groupId":"OG004","value":"32"},{"groupId":"OG005","value":"31"},{"groupId":"OG006","value":"95"},{"groupId":"OG007","value":"31"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"68"}]}]},{"title":"Yes","categories":[{"measurements":[{"groupId":"OG000","value":"1"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"3"},{"groupId":"OG003","value":"6"},{"groupId":"OG004","value":"2"},{"groupId":"OG005","value":"2"},{"groupId":"OG006","value":"2"},{"groupId":"OG007","value":"1"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"1"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Increase of Alkaline Phosphatase (AP) to >2*Baseline","description":"Increase of AP to more than two times the baseline value","populationDescription":"All treated patients. No statistical comparisons due to extremely small number of cases","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"99"},{"groupId":"OG004","value":"34"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"98"},{"groupId":"OG007","value":"33"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}],"classes":[{"title":"Missing","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"1"},{"groupId":"OG007","value":"1"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"1"}]}]},{"title":"No","categories":[{"measurements":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"98"},{"groupId":"OG004","value":"33"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"97"},{"groupId":"OG007","value":"32"},{"groupId":"OG008","value":"29"},{"groupId":"OG009","value":"69"}]}]},{"title":"Yes","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"0"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"1"},{"groupId":"OG009","value":"0"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Increase of Bilirubin to >2*Baseline","description":"Increase of Bilirubin to more than two times the baseline value","populationDescription":"All treated patients. No statistical comparisons due to extremely small number of cases","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"99"},{"groupId":"OG004","value":"34"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"98"},{"groupId":"OG007","value":"33"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}],"classes":[{"title":"Missing","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"1"},{"groupId":"OG007","value":"1"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"1"}]}]},{"title":"No","categories":[{"measurements":[{"groupId":"OG000","value":"55"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"25"},{"groupId":"OG003","value":"86"},{"groupId":"OG004","value":"31"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"88"},{"groupId":"OG007","value":"29"},{"groupId":"OG008","value":"29"},{"groupId":"OG009","value":"63"}]}]},{"title":"Yes","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"2"},{"groupId":"OG003","value":"13"},{"groupId":"OG004","value":"3"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"9"},{"groupId":"OG007","value":"3"},{"groupId":"OG008","value":"1"},{"groupId":"OG009","value":"6"}]}]}]},{"type":"SECONDARY","title":"Number of Participants With Increase of Alanine-Aminotransferase (ALT) to >2*Baseline","description":"Number of Participants with Increase of ALT to more than two times the baseline value","populationDescription":"All treated patients. No statistical comparisons due to extremely small number of cases","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"Participants","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"BIBR 1048 50 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG001","title":"BIBR 1048 50 mg b.i.d + ASA 81 mg q.d.","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG002","title":"BIBR 1048 50 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG003","title":"BIBR 1048 150 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG004","title":"BIBR 1048 150 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG005","title":"BIBR 1048 150 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG006","title":"BIBR 1048 300 mg b.i.d","description":"bid (twice daily) oral"},{"id":"OG007","title":"BIBR 1048 300 mg b.i.d + ASA 81 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG008","title":"BIBR 1048 300 mg b.i.d + ASA 325 mg qd","description":"bid (twice daily) oral + qd (once daily) oral"},{"id":"OG009","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"qd (once daily) oral"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"58"},{"groupId":"OG001","value":"20"},{"groupId":"OG002","value":"27"},{"groupId":"OG003","value":"99"},{"groupId":"OG004","value":"34"},{"groupId":"OG005","value":"33"},{"groupId":"OG006","value":"98"},{"groupId":"OG007","value":"33"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"70"}]}],"classes":[{"title":"Missing","categories":[{"measurements":[{"groupId":"OG000","value":"0"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"0"},{"groupId":"OG003","value":"0"},{"groupId":"OG004","value":"0"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"1"},{"groupId":"OG007","value":"1"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"1"}]}]},{"title":"No","categories":[{"measurements":[{"groupId":"OG000","value":"55"},{"groupId":"OG001","value":"18"},{"groupId":"OG002","value":"26"},{"groupId":"OG003","value":"95"},{"groupId":"OG004","value":"33"},{"groupId":"OG005","value":"32"},{"groupId":"OG006","value":"93"},{"groupId":"OG007","value":"31"},{"groupId":"OG008","value":"30"},{"groupId":"OG009","value":"64"}]}]},{"title":"Yes","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"2"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"4"},{"groupId":"OG004","value":"1"},{"groupId":"OG005","value":"1"},{"groupId":"OG006","value":"4"},{"groupId":"OG007","value":"1"},{"groupId":"OG008","value":"0"},{"groupId":"OG009","value":"5"}]}]}]},{"type":"SECONDARY","title":"Severity of Adverse Events","description":"Total number of patients with any adverse event of worst intensity 'mild', 'moderate' and 'severe'.","populationDescription":"Treated patients(Numbers of patients for adverse events are counted for each treatment and are in their sum greater than the total number of patients randomized as 14 patients on Dabigatran with ASA changed treatment,12 patients down titrated Dabigatran bid to qd of which one did the down titration at the same time as the stop of the ASA treatment)","reportingStatus":"POSTED","paramType":"NUMBER","unitOfMeasure":"participants","timeFrame":"12 weeks","groups":[{"id":"OG000","title":"D50bid","description":"Dabigatran 50 mg twice daily"},{"id":"OG001","title":"D50qd","description":"Dabigatran 50 mg once daily"},{"id":"OG002","title":"D50bid + ASA81qd","description":"Dabigatran 50 mg twice daily + ASA 81 mg once daily"},{"id":"OG003","title":"D50bid + ASA325qd","description":"Dabigatran 50 mg twice daily + ASA 325 mg once daily"},{"id":"OG004","title":"D150bid","description":"Dabigatran 150 mg twice daily"},{"id":"OG005","title":"D150qd","description":"Dabigatran 150 mg once daily"},{"id":"OG006","title":"D150bid + ASA81qd","description":"Dabigatran 150 mg twice daily + ASA 81 mg once daily"},{"id":"OG007","title":"D150qd + ASA81qd","description":"Dabigatran 150 mg once daily + ASA 81 mg once daily"},{"id":"OG008","title":"D150bid + ASA325qd","description":"Dabigatran 150 mg twice daily + ASA 325 mg once daily"},{"id":"OG009","title":"D150qd + ASA325qd","description":"Dabigatran 150 mg once daily + ASA 325 mg once daily"},{"id":"OG010","title":"D300bid","description":"Dabigatran 300 mg twice daily"},{"id":"OG011","title":"D300qd","description":"Dabigatran 300 mg once daily"},{"id":"OG012","title":"D300bid + ASA81qd","description":"Dabigatran 300 mg twice daily + ASA 81 mg once daily"},{"id":"OG013","title":"D300qd + ASA81qd","description":"Dabigatran 300 mg once daily + ASA 81 mg once daily"},{"id":"OG014","title":"D300bid + ASA325qd","description":"Dabigatran 300 mg twice daily + ASA 325 mg once daily"},{"id":"OG015","title":"D300qd + ASA325qd","description":"Dabigatran 300 mg once daily + ASA 325 mg once daily"},{"id":"OG016","title":"Warfarin, Dosed to Target INR 2.0 to 3.0","description":"Warfarin once daily"}],"denoms":[{"units":"Participants","counts":[{"groupId":"OG000","value":"59"},{"groupId":"OG001","value":"1"},{"groupId":"OG002","value":"21"},{"groupId":"OG003","value":"27"},{"groupId":"OG004","value":"100"},{"groupId":"OG005","value":"3"},{"groupId":"OG006","value":"36"},{"groupId":"OG007","value":"1"},{"groupId":"OG008","value":"33"},{"groupId":"OG009","value":"1"},{"groupId":"OG010","value":"105"},{"groupId":"OG011","value":"3"},{"groupId":"OG012","value":"34"},{"groupId":"OG013","value":"2"},{"groupId":"OG014","value":"30"},{"groupId":"OG015","value":"1"},{"groupId":"OG016","value":"70"}]}],"classes":[{"title":"Mild","categories":[{"measurements":[{"groupId":"OG000","value":"24"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"9"},{"groupId":"OG003","value":"16"},{"groupId":"OG004","value":"54"},{"groupId":"OG005","value":"1"},{"groupId":"OG006","value":"23"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"17"},{"groupId":"OG009","value":"0"},{"groupId":"OG010","value":"47"},{"groupId":"OG011","value":"1"},{"groupId":"OG012","value":"23"},{"groupId":"OG013","value":"2"},{"groupId":"OG014","value":"23"},{"groupId":"OG015","value":"1"},{"groupId":"OG016","value":"30"}]}]},{"title":"Moderate","categories":[{"measurements":[{"groupId":"OG000","value":"13"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"6"},{"groupId":"OG003","value":"7"},{"groupId":"OG004","value":"19"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"9"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"4"},{"groupId":"OG009","value":"0"},{"groupId":"OG010","value":"23"},{"groupId":"OG011","value":"0"},{"groupId":"OG012","value":"5"},{"groupId":"OG013","value":"1"},{"groupId":"OG014","value":"11"},{"groupId":"OG015","value":"1"},{"groupId":"OG016","value":"14"}]}]},{"title":"Severe","categories":[{"measurements":[{"groupId":"OG000","value":"3"},{"groupId":"OG001","value":"0"},{"groupId":"OG002","value":"1"},{"groupId":"OG003","value":"1"},{"groupId":"OG004","value":"4"},{"groupId":"OG005","value":"0"},{"groupId":"OG006","value":"2"},{"groupId":"OG007","value":"0"},{"groupId":"OG008","value":"1"},{"groupId":"OG009","value":"0"},{"groupId":"OG010","value":"6"},{"groupId":"OG011","value":"0"},{"groupId":"OG012","value":"1"},{"groupId":"OG013","value":"0"},{"groupId":"OG014","value":"2"},{"groupId":"OG015","value":"0"},{"groupId":"OG016","value":"2"}]}]}]}]},"adverseEventsModule":{"frequencyThreshold":"5","timeFrame":"12 weeks","description":"Note that it was foreseen per protocol that all treatments were possibly to be down-titrated to BIBR 1048 q.d.; criteria included creatinine clearance and aPTT. Events are counted to the treatment on which they occurred.","eventGroups":[{"id":"EG000","title":"D50bid","description":"Dabigatran 50 mg twice daily","seriousNumAffected":5,"seriousNumAtRisk":59,"otherNumAffected":20,"otherNumAtRisk":59},{"id":"EG001","title":"D50qd","description":"Dabigatran 50 mg once daily","seriousNumAffected":0,"seriousNumAtRisk":1,"otherNumAffected":0,"otherNumAtRisk":1},{"id":"EG002","title":"D50bid + ASA81qd","description":"Dabigatran 50 mg twice daily + ASA 81 mg once daily","seriousNumAffected":2,"seriousNumAtRisk":21,"otherNumAffected":9,"otherNumAtRisk":21},{"id":"EG003","title":"D50bid + ASA325qd","description":"Dabigatran 50 mg twice daily + ASA 325 mg once daily","seriousNumAffected":1,"seriousNumAtRisk":27,"otherNumAffected":14,"otherNumAtRisk":27},{"id":"EG004","title":"D150bid","description":"Dabigatran 150 mg twice daily","seriousNumAffected":10,"seriousNumAtRisk":100,"otherNumAffected":43,"otherNumAtRisk":100},{"id":"EG005","title":"D150qd","description":"Dabigatran 150 mg once daily","seriousNumAffected":0,"seriousNumAtRisk":3,"otherNumAffected":1,"otherNumAtRisk":3},{"id":"EG006","title":"D150bid + ASA81qd","description":"Dabigatran 150 mg twice daily + ASA 81 mg once daily","seriousNumAffected":4,"seriousNumAtRisk":36,"otherNumAffected":19,"otherNumAtRisk":36},{"id":"EG007","title":"D150qd + ASA81qd","description":"Dabigatran 150 mg once daily + ASA 81 mg once daily","seriousNumAffected":0,"seriousNumAtRisk":1,"otherNumAffected":0,"otherNumAtRisk":1},{"id":"EG008","title":"D150bid + ASA325qd","description":"Dabigatran 150 mg twice daily + ASA 325 mg once daily","seriousNumAffected":2,"seriousNumAtRisk":33,"otherNumAffected":15,"otherNumAtRisk":33},{"id":"EG009","title":"D150qd + ASA325qd","description":"Dabigatran 150 mg once daily + ASA 325 mg once daily","seriousNumAffected":0,"seriousNumAtRisk":1,"otherNumAffected":0,"otherNumAtRisk":1},{"id":"EG010","title":"D300bid","description":"Dabigatran 300 mg twice daily","seriousNumAffected":3,"seriousNumAtRisk":105,"otherNumAffected":35,"otherNumAtRisk":105},{"id":"EG011","title":"D300qd","description":"Dabigatran 300 mg once daily","seriousNumAffected":0,"seriousNumAtRisk":3,"otherNumAffected":1,"otherNumAtRisk":3},{"id":"EG012","title":"D300bid + ASA81qd","description":"Dabigatran 300 mg twice daily + ASA 81 mg once daily","seriousNumAffected":4,"seriousNumAtRisk":34,"otherNumAffected":20,"otherNumAtRisk":34},{"id":"EG013","title":"D300qd + ASA81qd","description":"Dabigatran 300 mg once daily + ASA 81 mg once daily","seriousNumAffected":0,"seriousNumAtRisk":2,"otherNumAffected":2,"otherNumAtRisk":2},{"id":"EG014","title":"D300bid + ASA325qd","description":"Dabigatran 300 mg twice daily + ASA 325 mg once daily","seriousNumAffected":4,"seriousNumAtRisk":30,"otherNumAffected":18,"otherNumAtRisk":30},{"id":"EG015","title":"D300qd + ASA325qd","description":"Dabigatran 300 mg once daily + ASA 325 mg once daily","seriousNumAffected":0,"seriousNumAtRisk":1,"otherNumAffected":1,"otherNumAtRisk":1},{"id":"EG016","title":"Warfarin","description":"Warfarin once daily","seriousNumAffected":2,"seriousNumAtRisk":70,"otherNumAffected":22,"otherNumAtRisk":70}],"seriousEvents":[{"term":"Acute coronary syndrome","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":1,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":1,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Angina pectoris","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":1,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Atrial fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":1,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":1,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":1,"numAtRisk":70}]},{"term":"Atrial thrombosis","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":1,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Cardiac failure","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":1,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":2,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Cardiac failure congestive","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Ventricular fibrillation","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":1,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Ventricular tachycardia","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":1,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Dyspepsia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":1,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Gastric ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":1,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":1,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":1,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Ileus","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":1,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Lower gastrointestinal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":1,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Oesophageal ulcer","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":1,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Pancreatitis","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Rectal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":1,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Asthenia","organSystem":"General disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":1,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Cholecystitis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Cholelithiasis","organSystem":"Hepatobiliary disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":1,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Diverticulitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Pneumonia","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":2,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Implantable defibrillator malfunction","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":1,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Radius fracture","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":1,"numAtRisk":70}]},{"term":"Alanine aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":1,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Blood pressure systolic inspiratory decreased","organSystem":"Investigations","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":1,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Hypokalaemia","organSystem":"Metabolism and nutrition disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Neck pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":1,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Basal cell carcinoma","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":2,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Colon cancer","organSystem":"Neoplasms benign, malignant and unspecified (incl cysts and polyps)","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":1,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Cerebrovascular accident","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":1,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Epilepsy","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":1,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Paraesthesia","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Syncope","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":1,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Renal infarct","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":1,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":1,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Respiratory distress","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Skin discolouration","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Hip arthroplasty","organSystem":"Surgical and medical procedures","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Circulatory collapse","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Hypotension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":1,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Peripheral embolism","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]}],"otherEvents":[{"term":"Angina pectoris","organSystem":"Cardiac disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":1,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":1,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":1,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":2,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":1,"numAtRisk":70}]},{"term":"Conjunctival haemorrhage","organSystem":"Eye disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":2,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":1,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Eye haemorrhage","organSystem":"Eye disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":2,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":2,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":1,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Abdominal distension","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":2,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":1,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":1,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Abdominal pain","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":1,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":2,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":1,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":1,"numAtRisk":70}]},{"term":"Abdominal pain upper","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":1,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":3,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":1,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":3,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":1,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Constipation","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":1,"numAtRisk":21},{"groupId":"EG003","numAffected":4,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":1,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":2,"numAtRisk":70}]},{"term":"Diarrhoea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":2,"numAtRisk":21},{"groupId":"EG003","numAffected":3,"numAtRisk":27},{"groupId":"EG004","numAffected":3,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":2,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":2,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":3,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":2,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":1,"numAtRisk":70}]},{"term":"Dry mouth","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":1,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":2,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Dyspepsia","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":1,"numAtRisk":21},{"groupId":"EG003","numAffected":1,"numAtRisk":27},{"groupId":"EG004","numAffected":3,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":3,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":2,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":6,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":1,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":2,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Gingival bleeding","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":1,"numAtRisk":27},{"groupId":"EG004","numAffected":1,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":1,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":1,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":2,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Haemorrhoidal haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":1,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":1,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":2,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":1,"numAtRisk":70}]},{"term":"Mouth haemorrhage","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":2,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Nausea","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":2,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":4,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":1,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":1,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":2,"numAtRisk":34},{"groupId":"EG013","numAffected":1,"numAtRisk":2},{"groupId":"EG014","numAffected":1,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Vomiting","organSystem":"Gastrointestinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":2,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":1,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Chest pain","organSystem":"General disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":2,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":2,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":3,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":2,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":1,"numAtRisk":70}]},{"term":"Fatigue","organSystem":"General disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":2,"numAtRisk":27},{"groupId":"EG004","numAffected":5,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":3,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":5,"numAtRisk":34},{"groupId":"EG013","numAffected":1,"numAtRisk":2},{"groupId":"EG014","numAffected":1,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":3,"numAtRisk":70}]},{"term":"Sensation of pressure","organSystem":"General disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":1,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Influenza","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":2,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":1,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Nasopharyngitis","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":1,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":2,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":3,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":1,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Urinary tract infection","organSystem":"Infections and infestations","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":1,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":2,"numAtRisk":100},{"groupId":"EG005","numAffected":1,"numAtRisk":3},{"groupId":"EG006","numAffected":2,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":1,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":1,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":1,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":1,"numAtRisk":70}]},{"term":"Contusion","organSystem":"Injury, poisoning and procedural complications","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":2,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":2,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":3,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":2,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":3,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":6,"numAtRisk":70}]},{"term":"Alanine aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":1,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":1,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Aspartate aminotransferase increased","organSystem":"Investigations","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":1,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":1,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Back pain","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":2,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":1,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":1,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":2,"numAtRisk":70}]},{"term":"Costochondritis","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":1,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Pain in extremity","organSystem":"Musculoskeletal and connective tissue disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":2,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":2,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Dizziness","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":3,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":1,"numAtRisk":21},{"groupId":"EG003","numAffected":3,"numAtRisk":27},{"groupId":"EG004","numAffected":4,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":2,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":1,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":4,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":2,"numAtRisk":34},{"groupId":"EG013","numAffected":1,"numAtRisk":2},{"groupId":"EG014","numAffected":5,"numAtRisk":30},{"groupId":"EG015","numAffected":1,"numAtRisk":1},{"groupId":"EG016","numAffected":2,"numAtRisk":70}]},{"term":"Headache","organSystem":"Nervous system disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":2,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":1,"numAtRisk":21},{"groupId":"EG003","numAffected":4,"numAtRisk":27},{"groupId":"EG004","numAffected":2,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":2,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":3,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":1,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":2,"numAtRisk":70}]},{"term":"Haematuria","organSystem":"Renal and urinary disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":7,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":2,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":1,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Cough","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":3,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":3,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":1,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":3,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":1,"numAtRisk":34},{"groupId":"EG013","numAffected":1,"numAtRisk":2},{"groupId":"EG014","numAffected":1,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":1,"numAtRisk":70}]},{"term":"Dyspnoea","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":1,"numAtRisk":27},{"groupId":"EG004","numAffected":4,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":2,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":2,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":1,"numAtRisk":70}]},{"term":"Epistaxis","organSystem":"Respiratory, thoracic and mediastinal disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":1,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":1,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":4,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":2,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":2,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":5,"numAtRisk":70}]},{"term":"Ecchymosis","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":2,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":1,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":2,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":2,"numAtRisk":70}]},{"term":"Exanthem","organSystem":"Skin and subcutaneous tissue disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":0,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":0,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":1,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":0,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Haematoma","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":0,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":2,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":1,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":1,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":1,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":1,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":2,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":0,"numAtRisk":70}]},{"term":"Hypertension","organSystem":"Vascular disorders","sourceVocabulary":"MedDRA version 7.1","assessmentType":"SYSTEMATIC_ASSESSMENT","stats":[{"groupId":"EG000","numAffected":1,"numAtRisk":59},{"groupId":"EG001","numAffected":0,"numAtRisk":1},{"groupId":"EG002","numAffected":1,"numAtRisk":21},{"groupId":"EG003","numAffected":0,"numAtRisk":27},{"groupId":"EG004","numAffected":5,"numAtRisk":100},{"groupId":"EG005","numAffected":0,"numAtRisk":3},{"groupId":"EG006","numAffected":0,"numAtRisk":36},{"groupId":"EG007","numAffected":0,"numAtRisk":1},{"groupId":"EG008","numAffected":0,"numAtRisk":33},{"groupId":"EG009","numAffected":0,"numAtRisk":1},{"groupId":"EG010","numAffected":0,"numAtRisk":105},{"groupId":"EG011","numAffected":0,"numAtRisk":3},{"groupId":"EG012","numAffected":0,"numAtRisk":34},{"groupId":"EG013","numAffected":0,"numAtRisk":2},{"groupId":"EG014","numAffected":2,"numAtRisk":30},{"groupId":"EG015","numAffected":0,"numAtRisk":1},{"groupId":"EG016","numAffected":1,"numAtRisk":70}]}]},"moreInfoModule":{"certainAgreement":{"piSponsorEmployee":false,"restrictionType":"OTHER","restrictiveAgreement":true,"otherDetails":"Any publication of the result of this trial must be consistent with the Boehringer Ingelheim publication policy. The rights of the investigator and of the sponsor with regard to publication of the results of this trial are described in the investigator contract."},"pointOfContact":{"title":"Boehringer Ingelheim Call Center","organization":"Boehringer Ingelheim Pharmaceuticals","email":"clintriage.rdg@boehringer-ingelheim.com","phone":"1-800-243-0127"}}},"derivedSection":{"miscInfoModule":{"versionHolder":"2024-02-14"},"conditionBrowseModule":{"meshes":[{"id":"D000001281","term":"Atrial Fibrillation"}],"ancestors":[{"id":"D000001145","term":"Arrhythmias, Cardiac"},{"id":"D000006331","term":"Heart Diseases"},{"id":"D000002318","term":"Cardiovascular Diseases"},{"id":"D000010335","term":"Pathologic Processes"}],"browseLeaves":[{"id":"M21996","name":"Stroke","relevance":"LOW"},{"id":"M4276","name":"Atrial Fibrillation","asFound":"Atrial Fibrillation","relevance":"HIGH"},{"id":"M4143","name":"Arrhythmias, Cardiac","relevance":"LOW"},{"id":"M9109","name":"Heart Diseases","relevance":"LOW"}],"browseBranches":[{"abbrev":"BC10","name":"Nervous System Diseases"},{"abbrev":"BC14","name":"Heart and Blood Diseases"},{"abbrev":"All","name":"All Conditions"},{"abbrev":"BC23","name":"Symptoms and General Pathology"}]},"interventionBrowseModule":{"meshes":[{"id":"D000014859","term":"Warfarin"},{"id":"D000069604","term":"Dabigatran"}],"ancestors":[{"id":"D000000925","term":"Anticoagulants"},{"id":"D000000991","term":"Antithrombins"},{"id":"D000015842","term":"Serine Proteinase Inhibitors"},{"id":"D000011480","term":"Protease Inhibitors"},{"id":"D000004791","term":"Enzyme Inhibitors"},{"id":"D000045504","term":"Molecular Mechanisms of Pharmacological Action"}],"browseLeaves":[{"id":"M4238","name":"Aspirin","relevance":"LOW"},{"id":"M17292","name":"Warfarin","asFound":"Third","relevance":"HIGH"},{"id":"M490","name":"Dabigatran","asFound":"4 hours","relevance":"HIGH"},{"id":"M3934","name":"Anticoagulants","relevance":"LOW"},{"id":"M3997","name":"Antithrombins","relevance":"LOW"},{"id":"M3996","name":"Antithrombin III","relevance":"LOW"},{"id":"M14033","name":"Protease Inhibitors","relevance":"LOW"},{"id":"M18081","name":"Serine Proteinase Inhibitors","relevance":"LOW"},{"id":"M19299","name":"HIV Protease Inhibitors","relevance":"LOW"},{"id":"M7641","name":"Enzyme Inhibitors","relevance":"LOW"},{"id":"T18","name":"Serine","relevance":"LOW"}],"browseBranches":[{"abbrev":"Antipy","name":"Antipyretics"},{"abbrev":"Infl","name":"Anti-Inflammatory Agents"},{"abbrev":"ARhu","name":"Antirheumatic Agents"},{"abbrev":"FiAg","name":"Fibrinolytic Agents"},{"abbrev":"Analg","name":"Analgesics"},{"abbrev":"PlAggInh","name":"Platelet Aggregation Inhibitors"},{"abbrev":"All","name":"All Drugs and Chemicals"},{"abbrev":"AnCoag","name":"Anticoagulants"},{"abbrev":"Infe","name":"Anti-Infective Agents"},{"abbrev":"AA","name":"Amino Acids"}]}},"hasResults":true}